Keywords: مسدود کننده های کانال یونی; Fluoxetine; Ion channel blockers; Slow-channel congenital myasthenic syndrome; Neurodegenerative disease; Mutation; Acetylcholine receptor; Neuromuscular transmission; Neuromuscular junction; Ca2Â + overload; Subsynaptic DNA damage; Neuroprotective;